Victoza (GLP1 injection | daily) - Shipping and consultation fees included

・Appetite suppression・Prolonged satiety・Improved postprandial blood glucose・Weight management support

Administer subcutaneously once daily, as directed by your doctor.

It is recommended to administer at approximately the same time each day.

The prices shown include the consultation fee and medication costs.

・Nausea・Vomiting・Diarrhea・Constipation・Loss of appetite・Abdominal distension・Redness and pain at the injection site

・Use in conjunction with diet and exercise.
・Administer at the same time each day.
・Do not use with other GLP-1 preparations.
・If severe gastrointestinal symptoms persist, consult a doctor.

・Patients with a history of hypersensitivity to this drug
・Patients with severe gastroparesis
・Pregnant or lactating women
・Patients for whom the physician deems administration inappropriate

At our clinic, you can choose a shipping method from "Standard Shipping (Nekopos)", "Cool Delivery", or "Takkyubin Compact (+500 yen)", depending on the size of your package and your preference.

Standard Shipping (Nekopos)

・Delivered by post to your mailbox.
・You can receive it even if you are not home.
・Delivery date and time cannot be specified.

Cool Delivery (Recommended)

・Delivered in a refrigerated state.
・Cool delivery is recommended for injectable drugs to maintain their quality.
・Injectable drugs may degrade in quality if exposed to high temperatures.
・If quality defects are found during delivery,only products delivered via cool delivery are eligible for exchange.will be.

Takkyubin Compact (+500 yen)

・Received in person.
・Delivery date and time can be specified.
・After shipping, you can change the delivery date and time, or the pickup location such as a sales office or convenience store.

※Depending on the order content and quantity of products, we may change the shipping method to the most suitable one at our clinic. In that case, no additional shipping charges will be incurred.

For details on shipping methods, please refer to "About Shipping".

・Unapproved drugs, etc. (use for different purposes)

It is approved for the treatment of type 2 diabetes under the Pharmaceuticals and Medical Devices Act. However, its use for obesity treatment at our clinic is not approved in Japan.

・Source of acquisition, etc.We purchase domestically approved drugs from domestic pharmaceutical wholesalers.

・Availability of domestically approved drugsThere are GLP-1 preparations approved for manufacture and sale in Japan for the indication of obesity treatment.

・Safety information in other countriesInjectable GLP-1 receptor agonists are approved by the US FDA as obesity treatments.About the medication・Name: Victoza S.C. Injection 18mg・Generic name: Liraglutide (genetically modified)・Manufacturer and seller: Novo Nordisk Pharma Ltd.